Clinical Trials Logo

Clinical Trial Summary

Hiccup is a common symptom, and it is currently believed that hiccups result from diaphragmatic spasm, with onset ranging from minutes to days. Some patients may terminate on their own, or by ways such as gasping. For some patients with duration longer than 1 day, even longer than 2 days, medications may be needed, mainly: metoclopramide, eperisone hydrochloride tablets, etc. Acupuncture is also effective for some patients. Surgical treatment may be required for some clinically intractable hiccups. However, for the above interventions or treatment means, the current efficacy still needs to be improved. In the previous clinical experience, we create a new physical clinic protocol which could terminate the hiccup symptom onset instantaneously without adding extra cost to the patient, and the physiotherapy method was convenient and effective. To further validate the superiority, safety of this novel physical therapy regimen, we designed a randomised controlled, prospective, single centre clinical study aimed at comparing the efficacy and safety of the novel physical therapy with conventional pharmacotherapy in patients with hiccups.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05749159
Study type Interventional
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact Shen Jian
Phone +86 13634134320
Email sjcardiology@163.com
Status Recruiting
Phase N/A
Start date March 1, 2023
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Withdrawn NCT01277731 - Methylprednisolone Replacement for Dexamethasone-induced Hiccup N/A
Completed NCT05313685 - Educational Materials for Hiccups
Not yet recruiting NCT03778281 - Treatment of Chemotherapy-related Hiccups With Baclofen Phase 4